Strategic Acquisition Nextron is now part of the Amerita family, expanding nationwide reach and resources while maintaining its established home infusion focus in New Jersey. This presents cross-sell opportunities to Amerita’s broader client base and strengthens credentialing and payer access for rapid onboarding of new accounts.

Home Infusion Focus Strong specialization in at-home IV therapies (antibiotics, TPN, IVIG, Remicade) with a long track record and large patient base. Target growth among clinics and hospitals expanding outpatient infusion programs or outsourcing home infusion to reduce hospital-based complications and improve patient experience.

Operational Excellence End-to-end service model includes insurance verification, cost transparency, authorizations, on-site nursing administration, and patient education. Sales opportunities exist with providers seeking bundled infusion services, pharmacy integration, and nurse-led care management in home settings.

Scale and Reach Proof of large infusion volume (over 2 million infusions) demonstrates capability to manage high-demand, high-complexity cases. Position Nextron as a reliable partner for health systems needing scalable at-home infusion capabilities to balance cost and patient satisfaction.

Growth Potential Recent acquisition and nationwide expansion open doors for joint marketing to healthcare networks, GPOs, and payer partnerships. Potential to upsell broader Amerita services, technology-enabled enrollment, and enhanced pharmacy-to-patient delivery workflows.